Cargando…
Loading, please waitA no-hype, step-by-step walkthrough of what stem cell treatment in Cancún actually involves, from medical evaluation to follow-up, so you know what happens before you book a trip.
An honest, evidence-based look at how regenerative medicine is being used for chronic and autoimmune conditions, what the science supports, where it is still emerging, and who may be a candidate.
A clinical, non-promotional guide to stem cell therapy for hip osteoarthritis — how MSCs work in the hip joint, what the WOMAC and VAS data realistically show, who is a candidate, when replacement is the better call, and how the evaluation works.
An honest, indication-by-indication clinical decision guide for when stem cell therapy is the right first option, when surgery is the right first option, when combining the two makes sense, and the red flags that mean delaying surgery would be a mistake.
A medically conservative look at where mesenchymal stem cell therapy may help chronic back pain — degenerative disc disease, facet and SI joint arthropathy, radiculopathy — and where it almost certainly will not. With realistic timelines, candidate criteria, and the red flags that point to emergency surgery instead.
A medically conservative, indication-by-indication look at what 'success rate' actually means in stem cell therapy, how to interpret responder rates, what numbers look like across the most common conditions we treat, and why the question itself often hides the answer that matters.
A clinical, evidence-aware comparison of the three main sources of mesenchymal stem cells used in regenerative medicine — bone marrow, adipose tissue, and umbilical cord — with a side-by-side table and condition-by-condition recommendations.
A medically conservative, indication-by-indication look at when stem cell therapy results appear, when they peak, and how long they typically last — with the factors that extend or shorten durability and an honest discussion of when a top-up dose makes sense.
An honest medical review of Tesamorelin (Egrifta): GHRH mechanism, clinical evidence for visceral fat, dosing, contraindications, and COFEPRIS regulation.
An honest review of TB-500 (synthetic thymosin beta-4): mechanism, 2026 clinical evidence, comparison with BPC-157, dosing, and COFEPRIS regulation.
An honest medical review of stem cell therapy for MS: the difference between MSC and HSCT, current clinical evidence, ideal candidates, and known limitations.
An honest medical review of mesenchymal stem cell therapy for SLE: immunomodulatory mechanisms, clinical evidence, ideal candidates, and COFEPRIS regulation.
How mesenchymal stem cell therapy can help in lumbar disc herniation: 2026 evidence, ideal candidates, and what to expect from the image-guided procedure.
An honest medical review of mesenchymal stem cell therapy for long COVID (PASC): anti-inflammatory mechanisms, clinical evidence, and integrative protocol.
An honest medical review of regenerative options for Hashimoto's thyroiditis: MSC immunomodulation, integrative protocol, and current evidence limitations.
An honest review of stem cell therapy for fibromyalgia and chronic fatigue syndrome: anti-inflammatory mechanisms, preliminary evidence, and integrative approach.
An honest medical review of stem cell, PRP, and shockwave therapy for erectile dysfunction: mechanisms, clinical evidence, and ideal candidates.
An honest physician-led review of mesenchymal stem cell therapy for type 2 diabetes: current evidence, mechanisms, candidacy, and regulatory context in Mexico.
An honest comparison of PRP, stem cells, and exosomes for androgenetic alopecia: clinical evidence, ideal candidates, and the Regeneris protocol.
A transparent breakdown of stem cell therapy cost in Mexico vs USA: why there's a difference, what a proper protocol includes, and how to evaluate a clinic.
An honest medical review of Sermorelin: GHRH 1-29 analog, clinical evidence, typical dosing, comparison with CJC-1295, and COFEPRIS regulation in Mexico.
An honest medical review of Selank: nootropic heptapeptide, anxiolytic mechanism, clinical evidence (largely Russian), intranasal dosing, and COFEPRIS context.
An honest medical review of PT-141 (bremelanotide): CNS mechanism, clinical evidence, comparison with PDE5 inhibitors, dosing, and Mexican regulation.
A practical pre-treatment guide for stem cell therapy: metabolic optimization, supplements, what to avoid, day-of procedure, and follow-up schedule.
An honest medical guide to peptide therapy safety: side-effect profiles by category, risks from unregulated sources, and why medical supervision matters.
A practical guide to insurance coverage for stem cell treatments outside your country, financing options, FSA/HSA usage, and how to evaluate reimbursement programs.
A clinical deep dive into exosomes: molecular composition, paracrine mechanisms, therapeutic applications, 2026 evidence, and COFEPRIS regulation.
How stem cells, PRP, and peptides complement each other in personalized regenerative protocols: clinical use cases, synergies, and precautions.
A complete guide to COFEPRIS for international patients: what it regulates, how to verify clinics, the farmacia magistral framework, and why it matters for safety.
What CJC-1295 and Ipamorelin are, how the GH secretagogue stack works, clinical evidence, typical dosing, and COFEPRIS regulatory context.
A clear guide to the difference between autologous and allogeneic stem cells: pros, cons, clinical contexts, and how to choose based on your condition.
An honest medical review of AOD-9604 (hGH 176-191 fragment): mechanism, limited clinical evidence, typical dosing, and COFEPRIS regulation in Mexico.
A clinical comparison of the two leading GLP-1-class peptides for chronic weight management in 2026, mechanisms, head-to-head trial data, side-effect profiles, cost, and how we decide which is right for each patient.
An honest, physician-led review of BPC-157, what the molecule is, what 2026 clinical evidence shows, how COFEPRIS regulates peptides in Mexico, and who is a reasonable candidate.
A complete guide to platelet-rich plasma (PRP) therapy: how it works, clinical indications, what to expect, and why it is a popular option in regenerative medicine.
Explore current evidence on stem cell therapy for knee osteoarthritis, how MSCs work in joints, ideal candidates, and what to expect from treatment in Mexico.
Learn about IV vitamin therapy types like Myers cocktail, NAD+ and glutathione, the clinical evidence behind them, benefits, risks, and candidacy.
What peptides are, how they work, and what the current evidence says about BPC-157, TB-500, CJC-1295, semaglutide, and GHK-Cu in regenerative medicine.
An honest comparison between surgical and regenerative approaches for joint, tendon, and musculoskeletal problems. When each option makes clinical sense and what questions to ask.
An evidence-based overview of current research into mesenchymal stem cells and exosomes for autoimmune diseases, including lupus, rheumatoid arthritis, and multiple sclerosis.
A practical timeline from day one to week twelve: permitted activities, warning signs, medical follow-up, and realistic expectations after regenerative therapy.
A clear explanation of what exosomes are, how they differ from stem cells, and why they are often discussed together in regenerative medicine.
A clear, medically grounded introduction to mesenchymal stem cells, where they come from, and why laboratory standards matter.
NAD+, telomeres, exosomes, and anti-aging peptides are everywhere in marketing. Here is an honest look at the evidence, the limitations, and what patients should realistically expect.
How regenerative medicine is helping athletes recover from tendon, ligament, and cartilage injuries faster and with better long-term outcomes.
Your no-hype, science-backed starting point for regenerative treatment in Mexico.
